Cargando…
Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
Brain metastases (BM) present a common cause of mortality and morbidity in several metastatic cancer entities. New therapeutic developments during the last decades, including targeted and immune-related therapies, have shown considerable extra- and intracranial response rates in specific subgroups o...
Autores principales: | Steindl, Ariane, Brastianos, Priscilla K, Preusser, Matthias, Berghoff, Anna S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633753/ https://www.ncbi.nlm.nih.gov/pubmed/34859231 http://dx.doi.org/10.1093/noajnl/vdab105 |
Ejemplares similares
-
New Approaches with Precision Medicine in Adult Brain Tumors
por: Leibetseder, Annette, et al.
Publicado: (2022) -
New developments in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018) -
Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018) -
Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017) -
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
por: Wolff, Ladislaia, et al.
Publicado: (2023)